Kobayashi Pharmaceutical Co Ltd - Company Profile
Powered by 
All the data and insights you need on Kobayashi Pharmaceutical Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Kobayashi Pharmaceutical Co Ltd Strategy Report
- Understand Kobayashi Pharmaceutical Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Kobayashi Pharmaceutical Co Ltd’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 30 Sep 2020 | Kobayashi Pharma Acquires Alva-Amco Pharmacal | Acquisition |
Kobayashi Pharmaceutical Co Ltd
|
Alva-Amco Pharmacal Companies LLC
|
| 15 May 2019 | Kobayashi Pharmaceutical to Acquire 100% Stake in Meitan Honpo | Acquisition |
Kobayashi Pharmaceutical Co Ltd
|
Meitanhonpo Co Ltd
|
| 02 Apr 2018 | Kobayashi Pharma Acquires Jiangsu Zhongdan Pharma | Acquisition |
Kobayashi Pharmaceutical Co Ltd
|
Jiangsu Zhongdan Pharmaceutical Co Ltd
|
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer